TPH  is pleased to introduce into the Australian market the SPRING2 Transcutaneous Pulsed Radio Frequency (TcPRF) device manufactured in the Netherlands by SPRINGLIFE. The SPRING2 has been developed for the treatment of pain in the extremities - Shoulder, Elbow, Wrist, Hip, Knee and Ankle. Several papers have been published on TcPRF for the treatment of pain in the extremities. In addition a number of studies are ongoing  and will be published in due course.

As it is such a light and compact device, it is very easy to use at multiple locations including non-clinical sites. The touchscreen display shows an intuitive user interface that guides you without effort through the different modes and possibilities. Treatment data (indexed on date and time of the treatment) can be stored on a USB memory stick.

A transcutaneous procedure is an ideal option when an invasive treatment is less suitable. It is much more convenient for the patient and it is a safe procedure. Transcutaneous treatments are increasingly performed on joints, such as knees and shoulders. For transcutaneous treatments SPRING2 automatically identifies the skin electrodes. The size of these
Springlife electrodes are recognized by the SPRING2®. For safety reasons the maximum output will be
adjusted to the detected size. Up to 4 Springlife electrodes of different sizes can be used simultaneously